Clinical trial Recruiting at 1 site Observational Women only

Endoscopic and robotic nipple-sparing mastectomy with immediate breast reconstruction

Official title: Prospective Cohort Study of Minimally Invasive Surgery Versus Traditional Open Surgery for Nipple Areola Preserving Mastectomy Combined with Immediate Prosthesis Reconstruction

Run by Peking University People's Hospital · NCT06748677 · Data updated 2026-11-12

This study is testing a new type of breast surgery that uses advanced techniques to remove cancer while keeping the nipple and immediately placing an implant to see if it helps patients feel better about their appearance and recover well.

Quick facts

Study typeObservational
SexWomen only
Enrollment484 (estimated)
SponsorPeking University People's Hospital
Academic / other
Drugs / interventionsradiation
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedJanuary 3, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2031
Registry record updatedJanuary 7, 2025
Trial IDNCT06748677 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women diagnosed with early-stage breast cancer (stage 0-IIIB) who are eligible for nipple-sparing mastectomy and immediate reconstruction.

Probably not a fit

Patients with metastatic breast cancer, bilateral breast cancer, or those who have previously undergone breast-conserving surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on evaluating the safety and aesthetic outcomes of endoscopic and robotic nipple-sparing mastectomy (NSM) combined with immediate prosthesis breast reconstruction for patients with early-stage breast cancer. It aims to gather large-scale prospective data to support the effectiveness of this surgical approach, which is designed to minimize physical and psychological trauma associated with breast cancer surgery. Patients will be monitored postoperatively and asked to complete Patient Reported Outcome Measures (PROMs) questionnaires to assess their satisfaction and recovery.

Why it matters

Potential benefit: If successful, this approach could significantly improve the quality of life and aesthetic outcomes for patients undergoing mastectomy.

How similar studies have gone: Previous literature suggests that similar approaches have shown promising results, but large-scale prospective data is still lacking.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Underwent surgical treatment at Peking University People's Hospital, with hospitalization records;
2. Preoperative core needle biopsy confirmed breast cancer;
3. The clinical stage of the tumor is stage 0-IIIB; 4)cT≤5cm, cN0/cN1,M0, And there is no tumor invasion of the nipple areola complex, skin, and chest wall;

5\) Intraoperative plan to use non biological patches (such as TiLoop) to partially or completely wrap the prosthesis 6) Signed agreement to participate in this study; 7) Can cooperate to complete the Patient Reported Outcome Measures (PROMs) questionnaire.

Exclusion Criteria:

1. Lack of clinical pathological data (such as imaging data, pathological data);
2. Pregnancy or lactation period;
3. Patients with metastatic breast cancer or bilateral breast cancer;
4. Have undergone breast conserving surgery/chest radiation therapy before;
5. Patients with nipple areola invasion and subsequent removal of nipple areola complex;
6. Failed to undergo curative surgery;

Where it's running

  • Peking University People's Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.